Alimera Sciences files for $75M IPO
Alpharetta, GA - Alimera Sciences, a biopharmaceutical company developing prescription opthalmic products, has filed with the U.S. Securities and Exchange Commission to raise about $75 million in an initial public offering of stock.
Alimera is developing treatments for diseases that affect the retina.
Founded in 2003, the company’s venture backers include Intersouth Partners, Scale Venture Partners, Domain Associates, Polaris Venture Partners and Venrock Associates.
http://www.techjournalsouth.com/news/article.html?item_id=5680

